Pfizer Inc. MBA Analytics Manager in New York, New York
Pfizer is constantly aiming to advance our business by delivering successful new medicines. Achieving these goals requires the organization to have a clear strategic approach to capital investment. The Portfolio and Decision Analysis group (PDA), part of the Chief Business Office (CBO) organization, is uniquely positioned within Pfizer to facilitate strategic discussions and to advise on tough investment and trade-off decisions for programs within the clinical portfolio. This role involves working in close collaboration with stakeholder groups (e.g., Worldwide Research, Development and Medical (WRDM), Global Product Development (GPD), Finance) to identify strategic issues, facilitate discussion, and implement qualitative and/or quantitative analyses to inform decision-making.
This role is dynamic, fast-paced, highly collaborative, and covers a broad range of R&D, commercial, and strategic topics that are critical to our business. In addition, we are constantly driving thought leadership with our business partners, and continuously seeking new and creative ways to communicate highly complex and dynamic information.
Establish highly collaborative, cross-functional relationships with WRDM, GPD, Finance and other key stakeholder groups
Support and lead cross-functional strategic R&D portfolio projects for senior stakeholders that identify portfolio trends, risks, and opportunities
Partner within Portfolio & Decision Analysis to ensure portfolio systems are up-to-date and reflect recent governance interactions; address portfolio-related questions for a variety of stakeholders
Proactively identify and develop new and creative ways to view the end-to-end portfolio that deliver insights on productivity
Support the design, planning, implementation, and continuous improvement of annual R&D portfolio prioritization process
Integrate project-level metrics into a cohesive end-to-end portfolio story to facilitate senior decision making
Understand and monitor ongoing portfolio changes, as well as implications for broader portfolio prioritization decisions
Apply appropriate analytical frameworks (e.g., multi-attribute valuation analyses) to help inform decision-making for ad hoc projects across Pfizer
Support and, where applicable, lead analyses across large cross-functional teams that guide strategic investment decisions by implementing decision analysis (DA) methodologies to evaluate alternatives and incorporate relevant cost, risk, and return inputs
Analytical thinker:Understands how to synthesize facts and information from varied data sources, both new and pre-existing, into discernable insights and perspectives
Strong data and information manager:Understands and uses analytical skills/tools to produce data in a clean, organized way to drive objective insights
Exceptional communicator:Can readily align interpersonal style with the individual needs of customers
Financial / quantitative modeler:Possesses strong understanding and expertise of expected cash flow modeling, economic value measures (e.g., NPV, IRR), and other types of analytical modeling
Collaborator:Manages projects with and through others; shares responsibility and credit; develops self and others through teamwork; helps others take appropriate risks; communicates frequently with team members earning respect and trust ofthe team
Proactive self-starter: Takes an active role in one's own professional development; stays abreast of analytical trends, and cutting-edge applications of data
Professional experience and educational requirements
Successful completion of Pfizer Analytics 2020 Summer Associate Program
Undergraduate degree in business, economics, decision analysis, medicine / science, or related quantitative field
5+ years preferred experience in management consulting, investment banking, finance, strategic planning, portfolio management, or decision analysis
Experience in healthcare preferred, especially in biopharmaceuticals
Excellent Microsoft Excel and PowerPoint skills; experience with SQL or VBA a plus
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
Marketing and Market Research
EEO & Employment Eligibility:
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.